About this trial
Gestational diabetes mellitus (GDM) is a common metabolic disorder of pregnancy associated with increased maternal and fetal morbidity. Lactation has been suggested to improve maternal glucose metabolism, enhance insulin sensitivity, and reduce the risk of future glucose intolerance. However, evidence regarding the protective effect of lactation on the development of GDM in subsequent pregnancies remains limited.
This prospective observational cohort study aims to evaluate the association between lactation and the risk of gestational diabetes mellitus and related pregnancy complications in women who conceive during the lactation period. Routine glycemic markers including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results will be recorded. Ultrasonographic findings including fetal abdominal circumference percentile, estimated fetal weight percentile, and amniotic fluid index will also be assessed. The study will investigate whether lactation is associated with a reduced risk of GDM, fetal macrosomia, and polyhydramnios in subsequent pregnancies.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Pregnant individuals aged 18 to 50 years.
Singleton pregnancy.
Conception during the lactation period.
Follow-up at Prof. Dr. Cemil Taşcıoğlu City Hospital or Esenyurt Necmi Kadıoğlu State Hospital.
Disqualifiers
Age below 18 years.
Age above 50 years.
Multiple pregnancy.
Known chronic systemic disease or pre-existing diabetes mellitus.
Trial population
Pregnant individuals aged 18-50 years who conceived during the lactation period and are receiving antenatal care at participating obstetrics and gynecology clinics. Participants must have singleton pregnancies and available routine glycemic and ultrasonographic follow-up data. The study population represents women undergoing standard prenatal care in a tertiary care and secondary care hospital setting.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Incidence of Gestational Diabetes Mellitus
Occurrence of gestational diabetes mellitus diagnosed by the 75-g oral glucose tolerance test performed between 24 and 28 weeks of gestation.
Secondary outcomes
Fetal Macrosomia
Presence of fetal macrosomia assessed according to routine obstetric ultrasonographic evaluation and/or birth weight.
Other outcomes
Polyhydramnios
Development of polyhydramnios determined by routine ultrasonographic assessment of amniotic fluid volume during pregnancy.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.